配股筹10亿港元背后,这家药企的BD预期到底如何?

CPHI制药在线
30 Jun

关注并星标CPHI制药在线近日,君实生物宣布,公司于6 月13日披露的配售4100万股新H股事项,已经于6月20日完成。本次配售的募集资金总额约为10.39亿港元,募集资金净额(经扣除佣金及估计开支后)约为10.26亿港元。公司拟将配售募集资金净额的70%用于创新药研发,如PD-1/VEGF双抗、EGFR/HER3 ADC、PD-1/IL-2融合蛋白及其它在研管线的开发;30%用于补充营运资金等...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10